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The electrospinning technique has the unique capability to create nanofibrous scaffolds that mimic the 
native tissue structure and are attractive for regenerative medicine [1,2]. Here, we show the use of 
sodium alginate, a natural polymer, for the production of electrospun nanofibers with adjustable 
biodegradability rate. Controlling the biodegradation of alginate nanofibers under physiological 
conditions is an indispensably important step in tissue engineering and drug delivery. Sodium alginate 
fibers are in fact readily soluble in aqueous environments, and therefore cross-linking procedures are 
necessary to increase their stability and structural integrity. Several approaches have been proposed to 
this aim, in particular, reactions with glutaraldehyde (GTA) and Ca2+ ion. For instance, the use of GTA 
poses numerous problems due to the release of toxic compounds during the degradation of the 
nanofibers in the body. Our approach is based on the modification of the chemical structure of the 
alginate nanofibers by acidification of carboxylate groups and formation of poly(alginic acid). The 
resulting nanofibrous scaffolds exhibit high biocompatibility, as proved by in-vitro assays.  Therefore, 
we developed a novel strategy to increase the water stability of alginate nanofibers, preserving their 
morphology and no cytotoxicity [3]. In this way, we tuned the biodegradation rate of the nanofibers, 
making them promising for biomedical applications. 
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